高级搜索

益气养阴中药联合FOLFOX4方案化疗对大肠癌术后患者免疫功能的影响

蔡滨, 许阳贤, 蒋海涛, 杨吉勇, 孙逊, 林天碧, 章学林, 张静喆

蔡滨, 许阳贤, 蒋海涛, 杨吉勇, 孙逊, 林天碧, 章学林, 张静喆. 益气养阴中药联合FOLFOX4方案化疗对大肠癌术后患者免疫功能的影响[J]. 肿瘤防治研究, 2014, 41(08): 932-935. DOI: 10.3971/j.issn.1000-8578.2014.08.017
引用本文: 蔡滨, 许阳贤, 蒋海涛, 杨吉勇, 孙逊, 林天碧, 章学林, 张静喆. 益气养阴中药联合FOLFOX4方案化疗对大肠癌术后患者免疫功能的影响[J]. 肿瘤防治研究, 2014, 41(08): 932-935. DOI: 10.3971/j.issn.1000-8578.2014.08.017
CAI Bin, XU Yangxian, JIANG Haitao, YANG Jiyong, SUN Xun, LIN Tianbi, ZHANG Xuelin, ZHANG Jingzhe. Effect of Yiqi Yangyin Recipe Combined with FOLFOX4 on Immune Function in Patients with Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 932-935. DOI: 10.3971/j.issn.1000-8578.2014.08.017
Citation: CAI Bin, XU Yangxian, JIANG Haitao, YANG Jiyong, SUN Xun, LIN Tianbi, ZHANG Xuelin, ZHANG Jingzhe. Effect of Yiqi Yangyin Recipe Combined with FOLFOX4 on Immune Function in Patients with Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2014, 41(08): 932-935. DOI: 10.3971/j.issn.1000-8578.2014.08.017

益气养阴中药联合FOLFOX4方案化疗对大肠癌术后患者免疫功能的影响

基金项目: 2012年上海市教委预算内科研项目(2012JW39)
详细信息
    作者简介:

    蔡滨(1974-),男,本科,主治医师,主要从事中西医结合消化道肿瘤研究

    通讯作者:

    许阳贤,E-mail:xuyangxian@163.com

  • 中图分类号: R735.3+4

Effect of Yiqi Yangyin Recipe Combined with FOLFOX4 on Immune Function in Patients with Colorectal Cancer

  • 摘要: 目的 观察益气养阴中药联合FOLFOX4方案化疗对大肠癌术后患者免疫功能的影响。方法 选择60例2009年1月—2012年6月期间在龙华医院普外科接受手术并住院完成完整化疗周期的结直肠癌患者,随机分为益气养阴中药联合化疗组(治疗组)和单纯化疗组(对照组),每组30例。两组均以FOLFOX4方案化疗,治疗组在化疗期间口服益气养阴中药,早晚各一次,分别观察患者术前、术后、及化疗各个周期前的各项免疫指标,比较两组免疫指标的变化及化疗的不良反应等变化。结果 治疗组化疗各周期前后各指标变化不明显,差异无统计学意义。治疗组和对照组在手术后CD4,CD4/CD8较手术前上升,CD8较手术前有明显下降,两组间比较差异无统计学意义。经过3周期的化疗后,治疗组和对照组比CD8下降、CD4/CD8上升(P<0.05),在经过6周期化疗后治疗组和对照组比CD8下降(P<0.01)、CD3、CD4、CD4/CD8上升(P<0.01),差异有统计学意义。而治疗组化疗期间的不良反应明显比对照组轻。结论 益气养阴中药能提高肠癌患者术后辅助化疗期间的免疫功能,同时能减轻化疗期间的不良反应。

     

    Abstract: Objective To observe the effect of Yiqi Yangyin recipe(YQYY, supplementing qi, nourishing yin) combined with postoperative adjuvant chemotherapy FOLFOX4 on immune function in patients with colorectal cancer. Methods Selected 60 patients with colorectal cancer from Department of General Surgery in Longhua Hospital received operation and were hospitalized to complete the full cycle of chemotherapy from January 2009 to June 2012. These 60 patients were equally randomized into two groups, treatment group, treated with YQYY combined with chemotherapy, and control group, treated with chemotherapy alone(n=30). Both groups received FOLFOX4 chemotherapy; moreover, treatment group took YQYY during chemotherapy, twice a day. The immune indicators were observed before and after operation, and before various cycles of chemotherapy. The changes of immune indicators and side effects of chemotherapy were analyzed. Results Index change in treatment group was not statistically significant before and after all cycles of chemotherapy. CD4, CD4/CD8 were increased after operation in treatment group and control group, but CD8 was significantly decreased (P>0.05).After 3 cycles of chemotherapy, CD8 was decreased, while CD4/CD8 was increased in both groups (P<0.05). CD3,CD4,CD4/CD8 were significantly increased while CD8 was significantly decreased after 6 cycles of chemotherapy in treatment group compared with control group(P<0.01). The side effects of chemotherapy in treatment group were significantly lighter than those in control group. Conclusion YQYY could improve the immune function and reduce the side effects in colorectal cancer patients during postoperative adjuvant chemotherapy.

     

  • [1] FL Greene, DL Page, ID Fleming et al. AJCC Cancer Staging Manual[M].6th edition.New York: Springer-Verlag, 2002: 435. [F.L. Greene, D.L. Page, I.D. Fleming, .AJCC [M].6 .ŦԼ:ʩ ָ , 2002: 435.]
    [2] State Administration of Traditional Chinese Medicine of the People's Republic of China. ZY/T001.1.001.9-94 Criteria of diagnosis and therapeutic effect of diseases and syndromes in traditional Chinese medicine[S]. Nanjing: Nanjing University Pr e s s , 1 9 9 4 . [ л *͹ ҽҩ .ZY/ T001.1.001.9-94 ҽ ֤ Ч ׼[S]. Ͼ : Ͼ ѧ ,1994. ]
    [3] Chen WF. Medical immunology[M].4th edition.Beijing: People’s Medical Publishing House Co., LTD,2006:220-8.[ ο .ҽѧ ѧ[M] 4 . : ޹ ˾,2006:220-8.]
    [4] Wang XY, Kazim L, Repasky EA, et al. Immunization with tumorderived ER chaperone gap170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease[J]. Int J Cancer,2003,105(2):226-31.
    [5] Sasada T, Kimura M, Yoshida Y, et al. CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression[J]. Cancer, 2003,98(5):1089-99.
    [6] Lu AP, Zhang SS, Zha QL, et al. Correlation between CD4, CD8 cell infiltration in gastric mucosa, Helicobacter pylori infection and symptoms in patients with chronic gastritis[J]. World J Gastro enterol,2005,11(16):2486-90.
    [7] Liu TS, Li L, Zhao N, et al. Regulatory T cells and their clinical significance in the patients with colorectal carcinoma[J]. Zhonghua Shi Yan Wai Ke Za Zhi,2008,25 8 :1016-7.[ , , , . * е Tϸ ı P ٴ [J] л ʵ ־,2008,25 8 :1016-7.]
    [8] He L,Meng XL,Wen G,et al.The dynamic changes and their correlation of PGE2 , IL-2 and CD4+/CD8+ in patients with colorectal carcinoma pre- and post-operation[J].Anhui Yi Ke Da Xue Xue Bao,2010, 45 4 :548-50.[ , , ĸ , . ǰ PGE2 IL-2 CD4+/CD8+ ı仯 [J]. ҽ ƴ ѧѧ ,2010, 45 4 :548-50.]
    [9] Shen P,Xu YX,Zhang JZ,et al.Promoting effect of Yi Qi Yang Yin Herbs on recovery of postoperative patients[J].Zhongguo Zhong Xi Yi Jie He Wai Ke Za Zhi,2001,7(2):71-2.[ ƽ, , ž , . ˵ĵ [J]. й ҽ ־,2001,7(2):71-2.]
    [10] Shan YF, Kang HB, Zhang RM, et al. Effects of jinlong capsules on immune functions of breast carcinoma patients undergoing postoperative chemotherapy[J].2014,41(5):456-9. [ɽԺ , , , . Ҷ ٰ ƻ ߹ ܵ Ӱ [J] 2014,41(5):456-9.] [
计量
  • 文章访问数:  1127
  • HTML全文浏览量:  277
  • PDF下载量:  760
  • 被引次数: 0
出版历程
  • 刊出日期:  2014-08-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭